Mouse Anti-Human CD1A (T6, LEU6)
- Known as:
- Mouse Antibody toHuman CD1A (T6, LEU6)
- Catalog number:
- 128-10015-2
- Product Quantity:
- 1 mg
- Category:
- -
- Supplier:
- Ray Biotech
- Gene target:
- Mouse Anti-Human CD1A (T6 LEU6)
Related genes to: Mouse Anti-Human CD1A (T6, LEU6)
- Gene:
- CD1A NIH gene
- Name:
- CD1a molecule
- Previous symbol:
- CD1
- Synonyms:
- -
- Chromosome:
- 1q23.1
- Locus Type:
- gene with protein product
- Date approved:
- 1988-05-11
- Date modifiied:
- 2017-07-07
Related products to: Mouse Anti-Human CD1A (T6, LEU6)
Related articles to: Mouse Anti-Human CD1A (T6, LEU6)
- Cutaneous Rosai-Dorfman disease (CRDD) is a rare extranodal histiocytosis that can mimic other dermatoses, particularly when hallmark emperipolesis is absent. - Source: PubMed
Publication date: 2026/04/17
Al-Soufi LinaMarashli AyaYounis RazanAlkasem Areeb SaeedHussein FirasAl-Shehabi Zuheir - Rosai-Dorfman disease is a rare non-Langerhans cell histiocytic disorder. It is common in male children and young adults of African descent. It is classified into sporadic and familial types. The most common clinical presentation is massive bilateral cervical lymphadenopathy associated with constitutional symptoms. Histiocytic emperipolesis is a diagnostic hallmark for Rosai-Dorfman disease. The diagnostic criteria for Rosai-Dorfman disease are large histiocytic cells that stain positive for CD68 and S100, but negative for CD1a. We present two cases of sporadic Rosai-Dorfman disease in two males of African descent. The first patient had classic nodal Rosai-Dorfman disease; however, he was initially misdiagnosed as lymphoma. He responded poorly to cytotoxic drugs, but achieved a durable complete remission with three cycles of oral prednisolone. The second case had both nodal and extranodal Rosai-Dorfman disease. He initially responded well to steroids, but the response was short-lived. However, he achieved complete remission with a combination of oral methotrexate and vincristine. Rosai-Dorfman disease usually has a simple and uncomplicated clinical course. There is no universal standard guideline for managing Rosai-Dorfman disease. However, patients with symptomatic disease, those experiencing emergency symptoms, and cases of relapse will require medical or surgical intervention to improve their outcomes. - Source: PubMed
Publication date: 2026/04/19
Evele GeorgeFrancine KouyaBardin Richard - Langerhans cell sarcoma (LCS) is a rare malignant neoplasm that relatively frequently presents with primary cutaneous involvement. Owing to its extreme rarity, it is necessary to characterize the clinicopathological features of cutaneous LCS. - Source: PubMed
Publication date: 2026/04/21
Xiong YuLiu WeipingZhang WenyanZhang HongyingZhao Sha - Langerhans cell histiocytosis (LCH) is a rare clonal myeloid neoplasm. Cardiac involvement is exceedingly uncommon in neonates. We report a term male neonate with prenatally detected pericardial effusion and a postnatally identified epicardial mass adherent to the left ventricle. Multimodal imaging demonstrated confinement to the visceral pericardium without myocardial infiltration. Biopsy confirmed LCH (CD1a, CD207, S-100, ALK, BRAFV600E) and staging excluded systemic disease. The patient remained hemodynamically stable and was managed conservatively after multidisciplinary evaluation. Serial imaging demonstrated complete spontaneous regression by 6Â months. Comprehensive staging and precise anatomical imaging can guide safe observation in isolated epicardial LCH. - Source: PubMed
Publication date: 2026/04/20
Rocha Lucas OliveiraBom Ana Paula Kuczynski PedroMinkov Milen - Erdheim-Chester disease (ECD) is a rare histiocytic disorder characterized by the infiltration of tissues with foamy, xanthomatous CD68/CD163-positive, CD1a-negative histiocytosis. Pediatric ECD with chorioretinal involvement is exceedingly rare. Clinical manifestations and ophthalmic imaging findings are atypical, leading to misdiagnosis or missed diagnosis. From an ophthalmological perspective, we share an extremely rare case of pediatric ECD with chorioretinal and central nervous system infiltration, highlighting the diagnostic challenges and expanding the phenotypic spectrum of intraocular manifestations. - Source: PubMed
Publication date: 2026/04/01
Zhong HongyuLiang LicongLu Fang